| INTRODUC TI ON
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.
1 Inducing tumour cells apoptosis by chemotherapy is a common treatment modality for inoperable tumour. 2 Some studies have shown that amyloid protein precursor (APP), which plays an important role in neuronal cells owing to their linkage with Alzheimer's disease, 3 aberrantly altered in many types of cancers.
However, the regulation of APP in tumour cells and its role in tumour cells remains unknown.-Epigallocatechin-3-gallate (EGCG) has been shown to possess a wide range of pharmacological properties, including anti-inflammatory and neuroprotective effects, which have been linked to the antioxidant/pro-oxidant properties of its polyphenol constituents. 4 Some studies have shown that EGCG inhibited hepatocellular carcinoma growth and induced apoptosis. 5 We previously also found that EGCG induced neuroblastoma apoptosis via inhibition of amyloid precursor protein. 6 However, little is known about the mechanism of EGCG on APP regulation in tumour.
The RNA-binding proteins (RBPs) interact with other proteins and RNAs to form different ribonucleoprotein (RNP) complexes, which participate in the post-transcriptional regulation of RNAs and which orchestrate the fate of those RNAs. 7 Human antigen R (HuR, also known as ELAVL1) is an important RNA-binding protein.
Some studies reported that HuR correlated with patient outcome in liver cancer and interacted with lncRNA-AK058003 to regulate proliferation and metastasis of hepatocellular carcinoma. 7 Furthermore, in neurons, studies showed that HuD interacted with the 3' UTRs of APP mRNA (encoding amyloid precursor protein) and BACE1 mRNA (encoding β-site APP-cleaving enzyme 1) and increased the half-lives of these mRNAs. 8 However, the role of HuR in APP expression and EGCG-regulated APP expression in tumour is not clear.
In this study, we first indicate that the role of EGCG in APP and 
| MATERIAL S AND ME THODS

| Cell cultured
HepG2 and PC12 are cultured in Dulbecco's modified essential medium (DMEM) supplemented with 10% FBS and 1% PenicillinStreptomycin according to manufactures' instruction (detailed in the "Supporting Information").
| EGCG treatment
See the "Supporting Information".
| MTT assay
MTT assay was performed according to manufactures' instruction (detailed in the "Supporting Information").
| Clone formation assay
Clone formation assay was performed according to manufactures' instruction (detailed in the "Supporting Information").
| Flow cytometry
Flow cytometry was performed according to manufactures' instruction (detailed in the "Supporting Information").
| Total mRNA extract and qRT-PCR assay
Total mRNA was extracted by Ultrapure RNA kit (CWBIO, China), and the concentration was measure by nanodrop2000
and reverse transcription to cDNA by Takara 5XPrimer Script RT Master Mix (for Real Time). qRT-PCR was performed according to manufactures' instruction (detailed in the "Supporting Information").
| Plasmid building and transfection
Plasmid building and transfection were performed according to manufactures' instruction (detailed in the "Supporting Information").
| Western blot
Western blot was performed according to manufactures' instruction (detailed in the "Supporting Information").
| mRNA stability study
mRNA stability study was performed according to manufactures' instruction (detailed in the "Supporting Information").
| Statistical analysis
All data were expressed as the mean ± SEM. Statistical analyses were performed using Excel. Group comparisons are using Student's t test, 2 tails and double sample isovariances hypothesis. P < 0.05 was considered significant.
| RE SULT
| EGCG induces tumour cells apoptosis and regulates Bax and Bcl-2 expression
We first evaluate the effect of EGCG on proliferation of HepG2 and Figure 1I ). Furthermore, we used a HuR inhibitor, Dihydrotanshinone I, also distinctly reduced the APP and ADAM10 level ( Figure 1J ). These results indicate that the reduction in APP and ADAM10 by EGCG was partly depended on HuR.
| EGCG reduces the expression of APP and ADAM10 via regulation of HuR in tumour cells
| HuR regulates the APP processing by increasing the phosphorylation level of ERK rather than stabilizing the stability of APP mRNA
As HuR is an RNA binding protein via controlling the stability and translation of target mRNAs, we next estimate the role of HuR in mRNA stability of APP and ADAM10. Unexpectedly, the decrease rate of APP and ADAM10 has no difference between the experiment group and control group in tumour cell treatment with actinomycin D (Figure 2A,B) . As Erk1/2 plays a key role in cell apoptosis and APP regulation, we hypothesize that HuR-regulated APP and ADAM10 level through Erk1/2 signalling pathway. Indeed, overexpression of HuR enhanced the phosphorylation of Erk1/2 in tumour cells ( Figure 2C) . Furthermore, the phosphorylation of Erk1/2 was reduced in tumour cells treated with EGCG ( Figure 2D ,E).
| D ISCUSS I ON
(-)-Epigallocatechin-3-gallate (EGCG) is the most abundant polyphenolic extract in green tea, and has been shown to possess a wide range of pharmacological properties, including antitumour and neuroprotective effects. 9 Some studies have shown that EGCG inhibited hepatocellular carcinoma growth and induced apoptosis, 5 but the exactly molecular mechanism is not yet clear.
One of the key findings in this study is the critical role of amyloid protein precursor in EGCG-induced HepG2 and PC-12 cells apoptosis. Amyloid precursor protein (APP) is a member of the APP family of proteins, and different enzymatic processing leads to the production of several derivatives that are shown to have distinct biological functions. 10 We previously found that EGCG induced neuroblastoma apoptosis via inhibition of amyloid precursor protein. 6 In this study, we first demonstrated that EGCG induced HepG2 and PC12 apoptosis and regulated apoptosis-related proteins Bax and Bcl-2 expression. Further research showed that the effect of EGCG-induced apoptosis was closely associated with APP, which was consistent with our previous study that EGCG induced neuroblastoma cells apoptosis via regulation of amyloid precursor protein. 6 To our surprise, EGCG also decreased ADAM10 level, a member of the ADAM family involved in multiple cellular processes such as cell proliferation, differentiation, migration and invasion. 11 Our results were in agreement with that silencing ADAM10 inhibits the growth of hepatocellular carcinoma cancer cells. 12 As Erk1/2 plays a key role in cell apoptosis and APP regulation, 14, 15 we hypothesized that HuR regulated APP and ADAM10 level through 
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